Paul Bernhard

Title: Paul Bernhard: Innovator in Pharmaceutical Chemistry

Introduction

Paul Bernhard is a notable inventor based in Slingerlands, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline polymorphs that have therapeutic applications.

Latest Patents

Bernhard holds a patent for "Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide." This patent discloses crystalline polymorphs that are useful as pharmaceutical agents. The methods of production and isolation of these polymorphs, as well as pharmaceutical compositions that include them, are also detailed in the patent. Notably, these crystalline polymorphs act directly on the pituitary gland cells to release growth hormone, showcasing their potential in medical treatments.

Career Highlights

Paul Bernhard is associated with Helsinn Therapeutics (U.S.), Inc., where he has been instrumental in advancing pharmaceutical innovations. His work focuses on the intersection of chemistry and medicine, leading to breakthroughs that can improve patient outcomes.

Collaborations

Bernhard has collaborated with notable colleagues, including Keith Lorimer and Seemon H Pines. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical agents.

Conclusion

Paul Bernhard's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key inventor in the field. His work continues to influence the development of effective treatments that can benefit patients worldwide.